Hong Kong health authorities are investigating a new monkeypox case involving a close contact of the city’s fifth confirmed infection, reported South China Morning Post’s Danny Mok. A Phase 3 clinical trial evaluating Siga Technologies’ (SIGA) antiviral tecovirimat, also known as TPOXX, has been enrolling adults and children with monkeypox infection in the United States, the National Institutes of Health previously announced. Chimerix (CMRX) and Bavarian Nordic (BVNRY) are other makers of smallpox vaccines. Reference Link
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SIGA:
- SIGA Technologies to Host Business Update Call on May 4th, 2023 Following Release of First Quarter 2023 Financial Results
- SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2022
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue